On Invalid Date, Edesa Biotech (NASDAQ: EDSA) reported Q4 2023 earnings per share (EPS) of -$0.54, up 39.33% year over year. Total Edesa Biotech earnings for the quarter were -$1.68 million. In the same quarter last year, Edesa Biotech's earnings per share (EPS) was -$0.89.
As of Q2 2024, Edesa Biotech's earnings has grown year over year. Edesa Biotech's earnings in the past year totalled -$7.72 million.
What is EDSA's earnings date?
Edesa Biotech's earnings date is Invalid Date. Add EDSA to your watchlist to be reminded of EDSA's next earnings announcement.
What was EDSA's revenue last quarter?
On Invalid Date, Edesa Biotech (NASDAQ: EDSA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Edesa Biotech's revenue was $0.00.
What was EDSA's revenue growth in the past year?
As of Q2 2024, Edesa Biotech's revenue has grown null year over year. Edesa Biotech's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.